Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis

BACKGROUND: Optimal management of anti-CD20-treated patients with multiple sclerosis (pwMS) is an important clinical task during the current severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic. OBJECTIVES: To characterize humoral and cellular immune responses to SARS-CoV-2 vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Tatjana, Otto, Carolin, Jones, Terry C, Pache, Florence, Schindler, Patrick, Niederschweiberer, Moritz, Schmidt, Felix A, Drosten, Christian, Corman, Victor M, Ruprecht, Klemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131414/
https://www.ncbi.nlm.nih.gov/pubmed/35575234
http://dx.doi.org/10.1177/13524585221094478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131414/
https://www.ncbi.nlm.nih.gov/pubmed/35575234
http://dx.doi.org/10.1177/13524585221094478

Ejemplares similares